SeekingAlpha
ARCA biopharma to merge with Oruka Therapeutics in all-stock transaction
AR
ARCA Biopharma Inc
ABIO · NASDAQ2.40
AR
2.40
USD-27.60-92.00%Day Range
0USD
2.40USD
52 Week Range
1.56USD
47.40USD
Market Cap
34.82MUSD
About
General Information
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US00211Y5069
CUSIP
67072M301
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
Highlights
PE Ratio
-
PEG Ratio
-
Book Value
2.25
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-5.88
Wall Street Target Price
7
EPS Estimate Current Year
0
EPS Estimate Next Year
0
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Profitability
Revenue TTM
0
Gross Profit TTM
0
EBITDA
-8,589,000
Profit Margin
0.00%
Return On Assets TTM
-14.35%
Return On Equity TTM
-20.05%
Revenue Per Share TTM
0
Qtly Revenue Growth YOY
0.00%
Diluted Eps TTM
-5.88
Qtly Earnings Growth YOY
0.00%
Valuation
Trailing PE
0.00
Forward PE
0
Price Sales TTM
0
Price Book MRQ
1.0689
Enterprise Value Revenue
0
Enterprise Value EBITDA
-1
Peers analysis
- CMXHFCSL Limited
169.54
3.19% - CSLLYCSL Ltd
86.83
0.51% - ARGNFargenx SE
655.00
0.00% - UCBJFUCB SA
194.85
0.00% - ALNYAlnylam Pharmaceuticals Inc
240.51
-7.01%
- NONOFNovo Nordisk A/S
79.80
-4.72% - REGNRegeneron Pharmaceuticals Inc
694.00
-3.22% - ARGXargenx NV ADR
665.60
-0.72% - VRTXVertex Pharmaceuticals Inc
412.28
-0.27% - UCBJYUCB SA ADR
97.63
-0.27%
What are you waiting for?Start making profit today
©
2025
All rights reserved